Anthrax Vaccine Maker to Open Second Plant in Frederick, Md.
Source: The Baltimore Sun via NewsEdge Corporation
The nation's sole licensed producer of anthrax vaccine will open a second plant in Frederick, a potential $100 million facility that adds to Maryland's growing strength in vaccine research and production.
Officials of Emergent BioLogics Inc. -- a unit...
Emergent BioSolutions also owns Antex BioLogics, a Frederick firm that specializes in vaccine research and development. Combined, the parent firm and its subsidiaries employ about 420 people, El-Hibri said.